Osaic Holdings’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACRS
BCM
Osaic Holdings's ACRS Position: Q3 2026 in Review
Osaic Holdings increased its Aclaris Therapeutics (ACRS) stake by 1.8% in Q3 2026, buying an estimated $74 and bringing the position to 748 shares worth $3.95K. The position accounts for ﹤0.01% of the portfolio, ranked #7086.
Osaic Holdings first reported a position in ACRS in Q1 2020 and has held it in 19 quarters since. The position peaked at $73K in Q1 2021. 167 funds tracked by Wall St. Rank hold ACRS as of Q3 2026.
- Osaic Holdings held 748 shares of Aclaris Therapeutics worth $3.95K as of Q3 2026.
- Osaic Holdings bought 13 Aclaris Therapeutics shares in Q3 2026, an estimated $74.
- Aclaris Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7086 holding.
- Osaic Holdings first reported a position in Aclaris Therapeutics in Q1 2020 and has held it in 19 quarters since.
- Osaic Holdings's Aclaris Therapeutics position peaked at $73K in Q1 2021.
- 167 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.